These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 412133)

  • 1. Haloperidol in barbiturate detoxification.
    Snyder R
    Mil Med; 1977 Nov; 142(11):885-6. PubMed ID: 412133
    [No Abstract]   [Full Text] [Related]  

  • 2. Withdrawal treatment for barbiturate dependence.
    Teggin AF; Bewley TH
    Practitioner; 1979 Jul; 223(1333):106-7. PubMed ID: 482237
    [No Abstract]   [Full Text] [Related]  

  • 3. Barbiturate withdrawal.
    JAMA; 1979 Apr; 241(14):1447. PubMed ID: 430676
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal.
    Greenblatt DJ; Gross PL; Harris J; Shader RI; Ciraulo DA
    J Clin Psychiatry; 1978 Aug; 39(8):673-5. PubMed ID: 681307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique.
    Robinson GM; Sellers EM; Janecek E
    Clin Pharmacol Ther; 1981 Jul; 30(1):71-6. PubMed ID: 7237901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient barbiturate withdrawal using phenobarbital.
    Gray GR; Smith DE; Wesson DR; Sheppard CW
    Int J Addict; 1972; 7(1):17-26. PubMed ID: 5043836
    [No Abstract]   [Full Text] [Related]  

  • 7. Barbiturate physical dependence in mice: effects of neuroleptics and diazepam on the withdrawal syndrome.
    Belknap JK
    Clin Toxicol; 1978; 12(4):427-34. PubMed ID: 26494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of drug dependence of the barbiturate type.
    Wikler A
    Am J Psychiatry; 1968 Dec; 125(6):758-65. PubMed ID: 5698445
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of barbiturate dependence induced by repeated electroconvulsions.
    Essig CF
    Arch Int Pharmacodyn Ther; 1970 Dec; 188(2):387-91. PubMed ID: 4331780
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful detoxification from methadone maintenance. Follow-up study of 38 patients.
    Riordan CE; Mezritz M; Slobetz F; Kleber HD
    JAMA; 1976 Jun; 235(24):2604-7. PubMed ID: 946864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.
    Ross MS; Moldofsky H
    Am J Psychiatry; 1978 May; 135(5):585-7. PubMed ID: 347954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propoxyphene withdrawal with clonidine.
    Johnson DA; Bohan ME
    Am J Psychiatry; 1983 Sep; 140(9):1217-8. PubMed ID: 6351643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intense pentazocine abstinence syndrome. Treatment of a clinical case].
    Carranza-Acevedo J; Estrada-Robles U
    Arch Invest Med (Mex); 1974; 5 SUPPL 1():257-60. PubMed ID: 4447425
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haloperidol in Sydenham's chorea. Double blind study in 22 patients].
    Franco R; Olivares L
    Bol Med Hosp Infant Mex; 1974; 31(2):267-78. PubMed ID: 4611452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Barbiturate dependence].
    Lukachev GIa; Laskova NB; Marsakova GD
    Sov Med; 1989; (4):112-6. PubMed ID: 2762911
    [No Abstract]   [Full Text] [Related]  

  • 16. An objective evaluation of haloperidol in Gilles de la Tourette's syndrome.
    Ford CV; Gottlieb F
    Dis Nerv Syst; 1969 May; 30(5):328-32. PubMed ID: 4890446
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulpiride--an antipsychotic agent: comparative trial vs. haloperidol.
    Cassano GB; Castrogiovanni P; Conti L; Bonollo L
    Psychopharmacol Bull; 1977 Jul; 13(3):41-3. PubMed ID: 18759
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a buzepide metiodide-haloperidol combination in treating functional intestinal disorders. Randomized double-blind controlled versus placebo study].
    Barbier JP; Dorf G; Gordin J; Krainik F; Neveu D; Parlier H; Richard P; Vitaux J; Fraitag B
    Ann Gastroenterol Hepatol (Paris); 1989 May; 25(3):123-8. PubMed ID: 2672998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of chlorpromazine hydrochloride in the treatment of barbiturate addiction with acute withdrawal syndrome.
    BROOKS W; DEUTSCH L; DICKES R
    Am J Psychiatry; 1955 Mar; 111(9):696-8. PubMed ID: 14350092
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide.
    Palestine ML; Alatorre E
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):289-99. PubMed ID: 822987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.